Welch Group’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$355K Buy
702
+42
+6% +$21.7K 0.01% 232
2026
Q2
$307K Hold
660
– – 0.01% 245
2026
Q1
$249K Hold
660
– – 0.01% 259
2025
Q4
$282K Hold
660
– – 0.01% 249
2025
Q3
$296K Hold
660
– – 0.01% 229
2025
Q2
$321K Hold
660
– – 0.01% 204
2025
Q1
$400K Hold
660
– – 0.02% 170
2024
Q4
$348K Hold
660
– – 0.02% 186
2024
Q3
$397K Hold
660
– – 0.02% 170
2024
Q2
$358K Buy
660
+325
+97% +$186K 0.02% 172
2024
Q1
$215K Buy
+335
New +$204K 0.01% 209

Other funds holding CHE

Welch Group's CHE Position: Q3 2026 in Review

Welch Group increased its Chemed (CHE) stake by 6.4% in Q3 2026, buying an estimated $21.7K and bringing the position to 702 shares worth $355K. The position accounts for 0.01% of the portfolio, ranked #232.

Welch Group first reported a position in CHE in Q1 2024 and has held it in 11 quarters since. The position peaked at $400K in Q1 2025. 253 funds tracked by Wall St. Rank hold CHE as of Q3 2026.

  • Welch Group held 702 shares of Chemed worth $355K as of Q3 2026.
  • Welch Group bought 42 Chemed shares in Q3 2026, an estimated $21.7K.
  • Chemed made up 0.01% of Welch Group's portfolio in Q3 2026, its #232 holding.
  • Welch Group first reported a position in Chemed in Q1 2024 and has held it in 11 quarters since.
  • Welch Group's Chemed position peaked at $400K in Q1 2025.
  • 253 funds tracked by Wall St. Rank held Chemed as of Q3 2026.

Based on Welch Group's 13F filing for Q3 2026, filed 29 Oct 2026.